Senator Investment Group’s Eli Lilly LLY Stock Holding History

Senator Investment Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-42,373	Closed	-$35M	–	59
2025 Q1	$35M	Sell	42,373 -42,728	-50%	-$35.6M	1.86%	26
2024 Q4	$65.7M	Buy	85,101 +63,101	+287%	+$52.2M	1.93%	9
2024 Q3	$19.5M	Buy	+22,000	New	+$19.8M	0.93%	41
2024 Q1	–	Sell	-18,000	Closed	-$10.5M	–	81
2023 Q4	$10.5M	Sell	18,000 -17,000	-49%	-$9.92M	0.45%	51
2023 Q3	$18.8M	Sell	35,000 -29,500	-46%	-$15.2M	1.06%	33
2023 Q2	$30.2M	Buy	+64,500	New	+$27M	1.36%	31
2022 Q1	–	Sell	-400,000	Closed	-$110M	–	86
2021 Q4	$110M	Buy	400,000 +25,000	+7%	+$6.34M	2.14%	15
2021 Q3	$86.6M	Sell	375,000 -25,000	-6%	-$6.17M	1.48%	22
2021 Q2	$91.8M	Buy	+400,000	New	+$80.3M	1.74%	18

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Senator Investment Group's LLY Position: Q2 2025 in Review

Senator Investment Group sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 42,373 shares — an estimated $35M sold.

Senator Investment Group first reported a position in LLY in Q2 2021 and held it in 9 quarters. The position peaked at $110M in Q4 2021. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Senator Investment Group reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
Senator Investment Group sold 42,373 Eli Lilly shares in Q2 2025, an estimated $35M.
Senator Investment Group first reported a position in Eli Lilly in Q2 2021 and held it in 9 quarters.
Senator Investment Group's Eli Lilly position peaked at $110M in Q4 2021.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Senator Investment Group's 13F filing for Q2 2025, filed 13 Aug 2025.